Symptomatic spinal canal stenosis

Symptomatic spinal canal stenosis (lumbar spinal stenosis, LSS) is a degenerative condition characterised by narrowing of the lumbar spinal canal, intervertebral foramina, or lateral recesses, causing compression of the cauda equina or individual nerve roots. It is the most common reason for spinal surgery in adults over 65 years in Australia. The hallmark symptom is neurogenic claudication — bilateral lower limb pain, paraesthesia, or weakness provoked by walking and relieved by rest or lumbar flexion. Australian GPs play a central role in diagnosis, conservative management, and appropriate specialist referral.

Key Facts

• Most common spinal surgery indication in adults over 65 years in Australia
• Prevalence: 11–13% of adults over 60 years; incidence increasing with ageing population
• Aetiology: multifactorial degenerative — disc degeneration, facet joint hypertrophy, ligamentum flavum thickening, osteophyte formation
• Hallmark: neurogenic claudication — lower limb pain/weakness with walking, relieved by flexion or rest
• Distinction from vascular claudication: key diagnostic challenge
• Natural history: variable — many remain stable; minority progress to require surgery
• Most patients managed conservatively; surgery reserved for those with significant functional limitation or neurological deficit

Classification

Lumbar spinal stenosis results from age-related degenerative changes across multiple spinal structures acting in concert to reduce canal dimensions and compress neural elements. The cauda equina and exiting nerve roots have limited tolerance to mechanical compression and ischaemia, particularly under loaded (upright, extended) postures.

Mechanisms of Canal Narrowing

• Disc degeneration: Loss of disc height causes buckling of the posterior longitudinal ligament and annular bulge into the canal; reduced foraminal height compresses exiting nerve roots
• Facet joint hypertrophy: Degenerative osteoarthritis of the facet (zygapophyseal) joints causes osteophyte formation and joint capsule thickening — major contributor to lateral recess and foraminal stenosis
• Ligamentum flavum hypertrophy: Repeated microtrauma and degenerative change leads to thickening and buckling of the ligamentum flavum into the posterior canal — key contributor to central stenosis
• Osteophyte formation: Vertebral end plate and facet joint osteophytes directly encroach on the canal and foramina
• Spondylolisthesis: Degenerative forward slip of one vertebra on another (most common at L4/5) dynamically narrows the canal and is present in approximately 10–15% of LSS cases

Neurogenic Claudication Mechanism

• In lumbar extension (standing, walking), the canal narrows further — the ligamentum flavum buckles anteriorly and foramina decrease in height; neural compression and ischaemia increase
• Lumbar flexion (sitting, leaning forward) widens the canal — relieves compression and restores neural blood flow
• This explains the characteristic posture-dependent symptom pattern: symptoms worsen walking downhill (extension) and improve walking uphill (flexion) or pushing a shopping trolley
• Vascular compromise of the cauda equina underlies the claudication — not simply direct mechanical compression

Spinal canal stenosis typically presents in adults over 50 years with insidious onset of lower back pain and lower limb symptoms. The neurogenic claudication pattern is pathognomonic. A careful history distinguishes LSS from vascular claudication, radiculopathy, and peripheral neuropathy.

Typical Presenting Features

• Neurogenic claudication: Bilateral (or unilateral) lower limb pain, cramping, heaviness, paraesthesia, or weakness — provoked by walking or prolonged standing, relieved by sitting or lumbar flexion; typically starts in buttocks or thighs, radiates distally
• Low back pain: Present in majority; typically bilateral, diffuse, often chronic and pre-existing
• Leg pain / radiculopathy: May be unilateral if lateral recess or foraminal stenosis is predominant; dermatomal distribution (L4, L5, S1 most common)
• Postural relief: Sitting, shopping trolley sign (leaning on trolley relieves symptoms), walking uphill — characteristic
• Reduced walking distance: Progressive limitation of walking tolerance is the primary functional complaint
• Bladder/bowel dysfunction: Rare but important red flag — urinary urgency or retention suggests cauda equina compression

Clinical Examination

• Often relatively unremarkable — neurological examination may be normal between symptom episodes
• Lumbar range of motion: reduced extension; flexion typically preserved and may relieve symptoms
• Tandem gait test: walking heel-to-toe may reproduce symptoms
• Bicycle test (stationary cycling in flexion): does NOT provoke symptoms — distinguishes from vascular claudication
• Neurological examination: lower limb reflexes (reduced), myotomal weakness, dermatomal sensory loss — may be present in moderate-severe stenosis
• Peripheral pulses: assess for vascular disease contributing to claudication
• Waddell signs: assess for non-organic contributing factors in chronic cases

Distinguishing Neurogenic from Vascular Claudication

Diagnosis of LSS is primarily clinical, supported by imaging. MRI is the investigation of choice. Imaging findings must correlate with clinical symptoms — incidental stenosis on imaging is common in older adults and should not drive management.

• Essential
  MRI Lumbar Spine

  Investigation of choice for LSS. Demonstrates degree of canal narrowing, disc pathology, facet joint changes, ligamentum flavum hypertrophy, nerve root compression. Quantifies central canal AP diameter and cross-sectional area. Required before surgical planning. Avoid if contraindicated (pacemaker, metallic implants); proceed to CT myelography.
• Essential
  Clinical Assessment (History + Examination)

  Diagnosis of neurogenic claudication is primarily clinical. Zurich Claudication Questionnaire (ZCQ) or Swiss Spinal Stenosis Questionnaire may be used to characterise severity and monitor response to treatment.
• Recommended
  CT Lumbar Spine

  Alternative to MRI if MRI contraindicated. CT myelography is gold standard for surgical planning. Demonstrates bony anatomy well; inferior to MRI for soft tissue/disc/ligament assessment.
• Recommended
  Plain X-Ray Lumbar Spine

  Initial investigation in primary care. AP and lateral standing views: assess for spondylolisthesis, disc height loss, osteophytes, alignment. Limited sensitivity for canal stenosis. Cannot exclude stenosis.
• Available
  Ankle Brachial Index (ABI)

  Indicated if vascular claudication cannot be clinically excluded. ABI <0.9 suggests peripheral arterial disease. Note: mixed disease (vascular + neurogenic) occurs in ~15% of older patients.
• Available
  Nerve Conduction Studies / EMG

  Useful when peripheral neuropathy is suspected as primary or contributing diagnosis. Not routinely required for typical LSS presentation.

MRI Grading of Central Stenosis (Schizas Classification)

Risk stratification in LSS guides management intensity and urgency of specialist referral. Key determinants are symptom severity, functional limitation, neurological status, and patient fitness for potential surgery.

Prognostic Factors

• Natural history: Many patients remain stable or improve with conservative treatment over 4–10 years; approximately 15–20% deteriorate significantly
• Spondylolisthesis: Dynamic instability with spondylolisthesis predicts worse outcome without surgery; fusion may be required in addition to decompression
• Severity at presentation: Severe baseline functional limitation predicts worse conservative outcome
• Comorbidities: Obesity, diabetes, osteoporosis, cardiovascular disease — increase surgical risk and may complicate conservative management
• Psychosocial factors: Anxiety, depression, catastrophising — predict poorer treatment outcomes regardless of structural severity
• Bilateral vs unilateral symptoms: Bilateral neurogenic claudication (central stenosis pattern) has a more variable natural history than unilateral radiculopathy

Pharmacological management in LSS is directed at symptom control — primarily pain and neuropathic symptoms. There is no pharmacotherapy that reverses canal narrowing. Analgesics and neuropathic agents are used as part of a multimodal approach alongside physiotherapy and lifestyle modification.

When conservative management fails to provide adequate relief, interventional options (epidural steroid injections) and surgical decompression are considered. Surgery is effective for neurogenic claudication unresponsive to conservative care, particularly in patients who are fit and have confirmed imaging-clinical correlation.

Epidural Steroid Injections (ESI)

• Indication: Moderate-to-severe neurogenic claudication or radiculopathy with inadequate response to conservative management; bridge therapy while awaiting surgery
• Routes: Caudal, transforaminal, or interlaminar — performed under fluoroscopic or CT guidance; transforaminal preferred for foraminal stenosis
• Efficacy: Provides short-term (weeks to months) relief of leg pain in approximately 50–60% of patients; evidence for long-term benefit is limited
• Evidence: SPORT trial and NEJM data support short-term benefit; does not prevent eventual surgery in most patients
• Risks: Infection, haematoma, dural puncture, transient increase in pain; systemic corticosteroid effects (blood glucose elevation, adrenal suppression with repeated injections)
• Repeat injections: Maximum 3 injections per year per spinal level; diminishing returns with repeated injections

Surgical Options

• Laminectomy / decompression: Most common procedure — removal of lamina, ligamentum flavum, and partial facetectomy to decompress the canal; effective for neurogenic claudication with 70–80% good outcomes at 2 years
• Decompression + fusion (instrumented): Indicated when degenerative spondylolisthesis or instability is present; adds pedicle screw fixation and interbody fusion to prevent postoperative instability
• Minimally invasive decompression: Microsurgical or endoscopic techniques — smaller incisions, reduced blood loss and recovery time; comparable outcomes to open surgery in experienced hands
• Interspinous spacer devices (e.g., X-STOP): Less invasive; maintain lumbar flexion; suitable for select patients who cannot tolerate major surgery — lower complication rate but less durable outcomes
• Outcomes: Surgery is more effective than conservative treatment for moderate-severe symptoms at 4 years (SPORT trial); benefit over conservative care decreases over longer follow-up; reoperation rates 15–20% at 10 years

Physiotherapy and conservative non-pharmacological management are the cornerstone of initial treatment for LSS. Goals include pain reduction, functional improvement, and maintaining walking tolerance. Exercise does not alter canal dimensions but significantly improves symptoms and function through neuromuscular conditioning and posture adaptation.

Physiotherapy Program

• Flexion-based exercise program: Lumbar flexion exercises (pelvic tilts, knee-to-chest, lumbar flexion stretches) — alleviate compression in flexed posture; stationary cycling and swimming preferred aerobic modalities
• Core stabilisation: Transversus abdominis activation, multifidus strengthening — reduces lumbar instability and pain
• Aquatic (hydrotherapy) exercise: Particularly effective in elderly patients; reduces axial loading while allowing active exercise; improves pain and walking tolerance
• Treadmill walking with forward lean: Use of treadmill with mild incline (forward lean posture) allows graded walking reconditioning in a flexion-biased position
• Manual therapy: Soft tissue mobilisation, joint mobilisation — may provide short-term symptom relief; limited high-quality evidence for LSS specifically
• Postural training: Education on forward-lean posture for symptom management (shopping trolley technique); avoidance of prolonged lumbar extension

Activity and Lifestyle Modification

• Encourage daily low-impact activity: cycling (upright or stationary), swimming, aquatic exercise — these maintain fitness without exacerbating symptoms
• Walking aids: walking frame or shopping trolley provides forward-lean posture — effective symptom management strategy; do not discourage
• Avoid prolonged standing or walking in extension — use rest breaks in flexed position (sitting) during activities
• Weight management: obesity increases axial load and correlates with symptom severity; weight loss programs recommended in overweight patients
• Smoking cessation: smoking is associated with disc degeneration and impaired recovery
• Occupational modification: avoid jobs requiring prolonged standing or heavy lifting without rest; workplace ergonomics advice

Pain Management Adjuncts

• TENS (transcutaneous electrical nerve stimulation): modest short-term pain relief; evidence limited but low risk; may assist with mobilisation
• Heat therapy: local heat application to lumbar spine for muscle spasm and pain; safe adjunct
• Acupuncture: limited evidence specifically for LSS; some RCT data supporting short-term pain relief in non-specific low back pain
• Pain psychology / CBT: for chronic pain with significant psychosocial overlay; improves function and coping strategies

Monitoring in LSS focuses on symptom trajectory, functional capacity, neurological status, and response to treatment. Regular reassessment identifies patients who are deteriorating and require escalation of management.

Monitoring Tools

• Zurich Claudication Questionnaire (ZCQ): Validated disease-specific questionnaire for LSS — assesses symptom severity, physical function, and patient satisfaction; useful for tracking treatment response
• Visual Analogue Scale (VAS) or Numeric Rating Scale (NRS): Simple pain score monitoring at each review
• Timed walking test: Time to onset of claudication symptoms — objective measure of functional capacity
• Neurological examination: Reflexes, power, sensation at each visit — early detection of motor or sensory deterioration

Indications for Urgent/Expedited Specialist Referral

• Cauda equina syndrome: emergency referral — same-day
• Progressive motor weakness — urgent (within days)
• Failure of conservative management at 3 months with significant functional limitation
• Severe baseline stenosis on MRI (Schizas Grade C–D) with disabling symptoms
• Concurrent unstable spondylolisthesis

👴 Elderly Patients (>75 years)

• Most common age group — LSS is primarily a disease of older adults; symptom burden must be weighed against surgical risk in frail patients
• Conservative management preferred as first-line; surgery feasible in fit elderly patients with good outcomes
• Comorbidities (cardiovascular, renal, diabetes) affect both pharmacological choices (NSAIDs generally avoided) and surgical eligibility
• Falls risk is elevated in elderly LSS — neurological deficit, opioid or pregabalin use, gait disturbance all contribute; address falls prevention
• Polypharmacy review: NSAIDs, opioids, pregabalin, and duloxetine all increase falls risk in the elderly; use cautiously with geriatric input if needed

🩺 Patients with Diabetes

• Peripheral neuropathy from diabetes frequently co-exists with LSS and complicates diagnosis — both cause lower limb paraesthesia and weakness
• Nerve conduction studies can help distinguish neuropathic from compressive aetiology
• Epidural steroid injections cause transient blood glucose elevation — monitor closely in insulin-requiring patients for 1–2 weeks post-injection
• NSAIDs: caution with renal impairment (common in diabetes); monitor eGFR
• Pregabalin and gabapentin are useful for diabetic neuropathic pain and can address overlapping neuropathic LSS symptoms

❤️ Cardiovascular Disease

• Vascular claudication may co-exist with neurogenic claudication — mixed aetiology in ~15% of older patients
• Ankle-Brachial Index (ABI) measurement should be performed if vascular disease is suspected
• NSAIDs are generally contraindicated in heart failure and should be used with caution in patients with established cardiovascular disease
• Surgical candidacy: significant cardiovascular risk must be assessed preoperatively (cardiology consultation may be required)

🤰 Pregnancy

• LSS is uncommon in pregnancy (primarily affects older patients); lumbar radiculopathy is more common in pregnancy
• If lumbar stenosis co-exists with pregnancy: avoid NSAIDs (especially in second/third trimester); paracetamol is safe
• MRI (without gadolinium) is preferred imaging if neurological assessment required during pregnancy
• Cauda equina syndrome in pregnancy: emergency — urgent neurosurgical review

🏋️ Obesity

• Obesity increases axial spinal load, accelerates degenerative change, and worsens symptoms of LSS
• Weight loss is a disease-modifying conservative intervention — even modest weight reduction (5–10%) reduces symptom severity
• Surgical outcomes are worse in morbidly obese patients (BMI >40); optimising weight prior to elective surgery improves outcomes

Stewardship in LSS involves avoiding over-medicalisation, minimising opioid prescribing, using NSAIDs judiciously in older patients, and ensuring imaging and surgical decisions are appropriately targeted to clinical need.

Conservative-First Approach

• Structured physiotherapy (flexion-based exercise, core strengthening, aquatic therapy) should precede all interventional and surgical options for non-emergency presentations
• Multimodal analgesia: paracetamol + physiotherapy is first-line; escalate to NSAIDs, neuropathic agents, or interventional options only with inadequate response
• ESI is appropriate after conservative management failure but is a bridge, not a cure — surgical assessment should not be indefinitely delayed in patients with progressive symptoms

Imaging Stewardship

• Plain X-ray is appropriate initial imaging in primary care — assesses spondylolisthesis, disc height, and alignment
• MRI is indicated for neurological symptoms, red flags, or when surgical or interventional planning is needed — not for routine monitoring of stable symptoms
• Do not repeat MRI within 12 months unless symptoms significantly change
• CT myelography: reserved for pre-surgical planning when MRI is contraindicated

Long-term follow-up for LSS focuses on symptom management, maintenance of function, neurological surveillance, and timely identification of patients who require escalation of care. LSS is a degenerative condition that does not resolve; the goal is optimal functional status and quality of life.

Prevention

• No proven primary prevention for degenerative LSS — condition is largely age-related
• Risk factor modification: weight management, smoking cessation, and regular exercise may slow degenerative progression
• Ergonomic measures: avoiding prolonged heavy axial loading occupationally may reduce rate of disc and facet degeneration
• Secondary prevention (post-diagnosis): structured exercise programs, weight control, and activity modification prevent symptom deterioration and maintain function
• Post-surgical rehabilitation: structured physiotherapy is essential after decompression surgery to maximise functional recovery and prevent recurrence

• 01
  Katz JN, Zimmerman ZE, Mass H, Makhni MC. Diagnosis and Management of Lumbar Spinal Stenosis: A Review. JAMA. 2022;327(17):1688–1699.
• 02
  Deyo RA, Mirza SK. Lumbar Spinal Fusion. N Engl J Med. 2016;374(15):1474–1476.
• 03
  Weinstein JN, et al. Surgical versus nonoperative treatment for lumbar spinal stenosis: four-year results of the Spine Patient Outcomes Research Trial. Spine. 2010;35(14):1329–1338.
• 04
  Lurie J, Tomkins-Lane C. Management of lumbar spinal stenosis. BMJ. 2016;352:h6234.
• 05
  Ammendolia C, et al. Nonoperative treatment for lumbar spinal stenosis with neurogenic claudication: an updated systematic review. BMJ Open. 2016;6(1):e010057.
• 06
  Delitto A, et al. Surgery versus nonsurgical treatment of lumbar spinal stenosis: a randomized trial. Ann Intern Med. 2015;162(7):465–473.
• 07
  Royal Australian College of General Practitioners (RACGP). Prescribing Drugs of Dependence in General Practice. Melbourne: RACGP; 2023.
• 08
  Therapeutic Guidelines. Musculoskeletal and Injuries. Melbourne: Therapeutic Guidelines Ltd; 2024.
• 09
  Atlas SJ, Keller RB, Wu YA, Deyo RA, Singer DE. Long-term outcomes of surgical and nonsurgical management of lumbar spinal stenosis: 8 to 10 year results from the Maine Lumbar Spine Study. Spine. 2005;30(8):936–943.
• 10
  Australian Institute of Health and Welfare. Back problems: a snapshot. Canberra: AIHW; 2020.
• 11
  Zaina F, et al. Surgical versus non-surgical treatment for lumbar spinal stenosis. Cochrane Database Syst Rev. 2016;(1):CD010264.
• 12
  Jensen RK, Thomsen LH, Elsoe R, Jensen TS. MRI in patients with lumbar spinal stenosis. Best Pract Res Clin Rheumatol. 2016;30(6):1078–1092.
• 13
  Kreiner DS, et al. Evidence-based clinical guidelines for multidisciplinary spine care: diagnosis and treatment of degenerative lumbar spinal stenosis. Spine J. 2013;13(7):734–743.